Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer

Robert Wesolowski(The Ohio State University Wexner Medical Center), William E. Carson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Zaibo Li(The Ohio State University Wexner Medical Center), Erin Macrae(McGill University), Lianbo Yu(The Ohio State University), Daniel G. Stover(Harvard University), Himanshu Savardekar(The Ohio State University), Dionisia Quiroga(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jeffrey VanDeusen(The Ohio State University), Rachel M. Layman(The University of Texas MD Anderson Cancer Center), Sagar Sardesai(The Ohio State University Wexner Medical Center), Bhuvaneswari Ramaswamy(The Ohio State University), Hiroaki Nitta(Tucson Medical Center), Mathew Cherian(The Ohio State University Wexner Medical Center), Brooke Benner(Comprehensive Blood & Cancer Center), Megan Duggan(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Mahmoud Kassem(The Ohio State University), Nicole Williams(The Ohio State University), Thomas A. Mace(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Christopher McQuinn(The Ohio State University), Andrew Stiff(The Ohio State University)
BMC Cancer
May 19, 2020
Cited by 16


Related Papers